Literature DB >> 30327860

[Brief review of the diagnostics of pyoderma gangraenosum].

Joachim Dissemond1.   

Abstract

The diagnosis of pyoderma gangraenosum was previously made as a diagnosis of exclusion. For this reason repeated attempts have been made in recent years to develop new diagnostic scores, whereby the typical clinical and anamnestic aspects were usually taken into account and the relevant differential diagnoses were excluded. With the PARACELSUS score an evaluated diagnostic score was presented for the first time. The main diagnostic criteria of this score are a rapidly progressing disease, the assessment of relevant differential diagnoses and reddish-violaceous wound borders. If these criteria are or were present 3 points are given for each criterion. Secondary criteria with a score of 2 for each of the aspects are amelioration by immunosuppressant drugs, characteristically irregular (bizarre) ulcer shape, extreme pain of >4 on a visual analog scale and localization of the lesion at the site of trauma (pathergy phenomenon). Additional criteria worth one point are suppurative inflammation in histopathology, undermined deep wound borders and the association of relevant systemic diseases. An additive score of ≥10 makes the diagnosis of pyoderma gangraenosum very likely. The newly developed and evaluated PARACELSUS score is an easy to use clinical tool to objectify securing the diagnosis of pyoderma gangraenosum.

Entities:  

Keywords:  Chronic wound; Febrile neutrophilic dermatosis; PARACELSUS score; Pain; Pathergy

Mesh:

Year:  2018        PMID: 30327860     DOI: 10.1007/s00393-018-0553-z

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  8 in total

1.  Diagnostic criteria for pyoderma gangrenosum: results of a survey among dermatologic wound experts in Germany.

Authors:  Philipp Al Ghazal; Joachim Klode; Joachim Dissemond
Journal:  J Dtsch Dermatol Ges       Date:  2014-12       Impact factor: 5.584

Review 2.  Skin ulcers misdiagnosed as pyoderma gangrenosum.

Authors:  Roger H Weenig; Mark D P Davis; Patrick R Dahl; W P Daniel Su
Journal:  N Engl J Med       Date:  2002-10-31       Impact factor: 91.245

Review 3.  Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria.

Authors:  W P Daniel Su; Mark D P Davis; Roger H Weenig; Frank C Powell; Harold O Perry
Journal:  Int J Dermatol       Date:  2004-11       Impact factor: 2.736

4.  Patients with pyoderma gangrenosum - analyses of the German DRG data from 2012.

Authors:  Finja Jockenhöfer; Joachim Klode; Knut Kröger; Alexander Roesch; Philipp Al Ghazal; Joachim Dissemond
Journal:  Int Wound J       Date:  2015-08-06       Impact factor: 3.315

5.  Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts.

Authors:  Emanual Maverakis; Chelsea Ma; Kanade Shinkai; David Fiorentino; Jeffrey P Callen; Uwe Wollina; Angelo Valerio Marzano; Daniel Wallach; Kyoungmi Kim; Courtney Schadt; Anthony Ormerod; Maxwell A Fung; Andrea Steel; Forum Patel; Rosie Qin; Fiona Craig; Hywel C Williams; Frank Powell; Alexander Merleev; Michelle Y Cheng
Journal:  JAMA Dermatol       Date:  2018-04-01       Impact factor: 10.282

6.  The PARACELSUS score: a novel diagnostic tool for pyoderma gangrenosum.

Authors:  F Jockenhöfer; U Wollina; K A Salva; S Benson; J Dissemond
Journal:  Br J Dermatol       Date:  2018-05-06       Impact factor: 9.302

Review 7.  ["TRECID", TNFalpha related chronic inflammatory diseases - a new multiple diseases bridging concept].

Authors:  U Müller-Ladner; R Alten; A Heiligenhaus; J Kekow; S Koletzko; U Mrowietz; T Ochsenkühn; M Radke; K Reich; M Rudwaleit; S Schreiber
Journal:  Dtsch Med Wochenschr       Date:  2009-10-06       Impact factor: 0.628

8.  Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients.

Authors:  Philipp Al Ghazal; Katharina Herberger; Jörg Schaller; Anke Strölin; Norman-Philipp Hoff; Tobias Goerge; Hannelore Roth; Eberhard Rabe; Sigrid Karrer; Regina Renner; Jan Maschke; Thomas Horn; Julia Hepp; Sabine Eming; Uwe Wollina; Markus Zutt; Isabell Sick; Benno Splieth; Dorothea Dill; Joachim Klode; Joachim Dissemond
Journal:  Orphanet J Rare Dis       Date:  2013-09-08       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.